Plasma IgE and risk of exacerbation and mortality in COPD in the general population
Y. Çolak (Copenhagen, Denmark), T. S. Ingebrigtsen (Copenhagen, Denmark), B. G. Nordestgaard (Copenhagen, Denmark), J. L. Marott (Copenhagen, Denmark), P. Lange (Copenhagen, Denmark), J. Vestbo (Manchester, United Kingdom), S. Afzal (Manchester, United Kingdom)
Source: International Congress 2022 – Lung function and risk factors associated with obstructive lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Çolak (Copenhagen, Denmark), T. S. Ingebrigtsen (Copenhagen, Denmark), B. G. Nordestgaard (Copenhagen, Denmark), J. L. Marott (Copenhagen, Denmark), P. Lange (Copenhagen, Denmark), J. Vestbo (Manchester, United Kingdom), S. Afzal (Manchester, United Kingdom). Plasma IgE and risk of exacerbation and mortality in COPD in the general population. 3740
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|